ArticleGastroenterology & hepatology2022
Cessation of Nucleoside/Nucleotide Analogue Therapy in Chronic Hepatitis B HBeAg-Negative Patients.
Paul J Pockros et al.PubMed ↗Full text ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it